Skip to content

Different Clinicopathological Features of Non-Elderly Sigmoid Volvulus Patients

Different Clinicopathological Features of Non-Elderly Sigmoid Volvulus Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04360525
Enrollment
134
Registered
2020-04-24
Start date
2020-01-01
Completion date
2020-04-18
Last updated
2020-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pathology

Keywords

dolichocolon, volvulus, sigmoid, Parkinson, mental retardation, Hirschsprung's disease

Brief summary

Sigmoid volvulus is frequently seen in male patients over 60 years old. In the sigmoid volvulus \<60 age groups, the male/female ratio is close to each other. If sigmoid volvulus develops in \<60 age groups, it is more likely to be another underlying organic pathology.

Detailed description

Sigmoid volvulus is frequently seen in male patients over 60 years old. Here, the investigators aimed to investigate the causes of sigmoid volvulus developing in patients under 60 years of age. Patients diagnosed with sigmoid volvulus between 2009 and 2018 were retrospectively screened. The patients were divided into two as under 60 years old and above. The co-morbidity, mortality, morbidity, complications, age and gender data of the patients were analyzed. In the sigmoid volvulus \<60 age groups, the male/female ratio is close to each other. If sigmoid volvulus develops in \<60 age groups, it is more likely to be another underlying organic pathology.

Interventions

OTHERReasons

Causes of sigmoid volvulus

Sponsors

Inonu University
CollaboratorOTHER
Dr. Ersin Arslan Education and Training Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Sigmoid volvulus patients under the age of 60 * Sigmoid volvulus patients at the age of ≥60

Exclusion criteria

* Lack of data

Design outcomes

Primary

MeasureTime frameDescription
Mortalityup to three monthsElderly and young patients mortality
Morbidityup to three monthsElderly and young patients morbidity

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026